首页> 外文期刊>Microbiome >Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation
【24h】

Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation

机译:粪便菌群移植后难辨梭状芽胞杆菌患者肠道菌群的种类和属水平解析分析

获取原文
           

摘要

Background Clostridium difficile is an opportunistic human intestinal pathogen, and C. difficile infection (CDI) is one of the main causes of antibiotic-induced diarrhea and colitis. One successful approach to combat CDI, particularly recurrent form of CDI, is through transplantation of fecal microbiota from a healthy donor to the infected patient. In this study we investigated the distal gut microbial communities of three CDI patients before and after fecal microbiota transplantation, and we compared these communities to the composition of the donor’s fecal microbiota. We utilized phylogenetic Microbiota Array, high-throughput Illumina sequencing, and fluorescent in situ hybridization to profile microbiota composition down to the genus and species level resolution. Results The original patients’ microbiota had low diversity, was dominated by members of Gammaproteobacteria and Bacilli, and had low numbers of Clostridia and Bacteroidia. At the genus level, fecal samples of CDI patients were rich in members of the Lactobacillus, Streptococcus, and Enterobacter genera. In comparison, the donor community was dominated by Clostridia and had significantly higher diversity and evenness. The patients’ distal gut communities were completely transformed within 3 days following fecal transplantation, and these communities remained stable in each patient for at least 4 months. Despite compositional differences among recipients’ pre-treatment gut microbiota, the transplanted gut communities were highly similar among recipients post-transplantation, were indistinguishable from that of the donor, and were rich in members of Blautia, Coprococcus, and Faecalibacterium. In each case, the gut microbiota restoration led to a complete patient recovery and symptom alleviation. Conclusion We conclude that C. difficile infection can be successfully treated by fecal microbiota transplantation and that this leads to stable transformation of the distal gut microbial community from the one abundant in aerotolerant species to that dominated by members of the Clostridia.
机译:背景艰难梭菌是人的肠道肠道病原体,艰难梭菌感染(CDI)是抗生素引起的腹泻和结肠炎的主要原因之一。对抗CDI(特别是CDI复发形式)的一种成功方法是通过将粪便菌群从健康的供体移植到感染的患者中来。在这项研究中,我们调查了三名CDI患者在粪便菌群移植前后的远端肠道微生物群落,并将这些群落与供体粪便菌群的组成进行了比较。我们利用系统发育的菌群阵列,高通量Illumina测序和荧光原位杂交技术,将菌群组成剖析到属和物种水平的分辨率。结果原始患者的菌群多样性低,以γ-变形杆菌和芽孢杆菌为主,梭状芽孢杆菌和细菌的数量较少。在属水平上,CDI患者的粪便样本富含乳杆菌属,链球菌属和肠杆菌属。相比之下,捐助者社区以梭状芽胞杆菌为主导,并且多样性和均匀性明显更高。粪便移植后3天内,患者的远端肠道群落已完全转化,并且这些群落在每位患者中保持稳定至少4个月。尽管接受者的肠道菌群在组成上存在差异,但移植后的肠道菌群在移植后的接受者之间高度相似,与供体的区别不明显,并且富含蓝藻,肠球菌和费氏杆菌。在每种情况下,肠道菌群的恢复都能使患者完全康复并减轻症状。结论我们得出的结论是,粪便菌群移植可以成功治疗艰难梭菌感染,这将导致远端肠道微生物群落从丰富的耐氧菌种稳定转化为梭菌成员所主导的菌群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号